Table 3. Responses by dose and schedule.
Dosing Schedule | Dosage
|
N | CR | CRp | Marrow Response |
---|---|---|---|---|---|
Ida ∣ Vorinostat | |||||
| |||||
Schedule A | 12 mg/m2 ∣ 100 mg | 5 | 0 | 0 | 1 |
9 mg/m2 ∣ 100 mg | 10 | 1 | 0 | 0 | |
| |||||
Schedule B | 12 mg/m2 ∣ 100 mg | 3 | 0 | 0 | 0 |
12 mg/m2 ∣ 200 mg | 3 | 0 | 0 | 0 | |
12 mg/m2 ∣ 300 mg | 4 | 1 | 0 | 1 | |
12 mg/m2 ∣ 400 mg | 10 | 0 | 1 | 1 | |
12 mg/m2 ∣ 500 mg | 6 | 0 | 0 | 1 | |
| |||||
Totals | 41 | 2 | 1 | 4 |
N represents the total number of patients for each dose and schedule. Ida = Idarubicin. Schedule A is Ida given at 12 mg/m2 IV daily for 3 days with vorinostat given for 14 days. Schedule B is Ida given at 12 mg/m2 IV daily for 3 days with vorinostat given for 3 days. CR = Complete Response. CRp = Complete Response without platelet recovery.